Jammu and Kashmir is shifting its medicinal plant sector from forest-based harvesting to a ₹150 crore scientific farming mission. The six-year plan aims to standardize production, improve export quality, and support over 5,000 farmers and 80 new startups. This move intends to stabilize raw material supply for the pharmaceutical and wellness industries while reducing environmental stress on forest ecosystems.
The Jammu and Kashmir administration has announced a strategic move to formalize the medicinal and aromatic plant (MAP) sector. By investing ₹150 crore over the next six years, the government intends to transition production from wild harvesting in forest areas to organized, scientific cultivation across more than 1,700 hectares. This shift is designed to create a reliable supply chain for the rapidly growing AYUSH, pharmaceutical, and wellness sectors in India.
Scaling Up Commercial Cultivation
The initiative focuses on cluster-based farming in suitable agro-climatic zones, which allows for better management of crop quality and yields. Unlike wild collection, which often results in inconsistent quality and supply, scientific cultivation provides the traceability and standardization required by modern pharmaceutical companies. The program includes funding for high-quality planting material, certification, and the development of specialized processing centers. By moving cultivation to agricultural land, the government expects to protect fragile Himalayan ecosystems while providing farmers with a consistent, high-value commercial crop.
Impact on the Value Chain
A central goal of this mission is to move beyond selling raw, unprocessed herbs. The government’s roadmap includes investments in extraction units, branding, and marketing, which are intended to help local entrepreneurs capture more value from the supply chain. By establishing 25 export-oriented enterprises and 80 new startups, the project aims to integrate the region into the global herbal products market. This is expected to generate significant employment in packaging, logistics, and secondary processing.
Challenges and Market Context
While the plan aims for long-term economic growth, investors and stakeholders should monitor several factors. The transition to commercial-scale farming carries execution risks, including the need for specialized knowledge among farmers and the ability to maintain uniform quality across different clusters to meet international standards. Furthermore, the financial success of this mission will depend on the government’s ability to build effective market linkages between small-scale farmers and large-scale industrial buyers.
Historically, the medicinal plant sector has faced difficulties with price volatility and the lack of organized infrastructure, which often limits the income potential for growers. The long-term success of this ₹150 crore investment will hinge on the uptake of these new farming techniques by local farmers and the competitive pricing of the final processed extracts compared to established global suppliers. Monitoring the progress of processing unit commissioning and the actual increase in hectares brought under cultivation will be key to evaluating the mission’s effectiveness.